Ledger.Open graph →
SEC Form D · filed July 6, 2016

Recombine Genomics, Inc

Offering
$10.0M
Sold
$8.4M
Exemption
Rule 506(b)
Industry
Other Technology
Location
NEW YORK, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Mathias Turck · New York, NYDirectorSantiago Munne · New York, NYDirectorAlexander Bisignano · New York, NYExec · DirectorMathias Turck · New York, NYDirectorSantiago Munne · New York, NYDirectorAlexander Bisignano · New York, NYExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗